Article
Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis
2021-01-12
Abstract excerpt
<h4>Background: </h4> Cancer patients are more likely to develop and die of bloodstream infection (BSI) than noncancer patients. Methicillin-resistant Staphylococcus aureus (MRSA), which is associated with immense mortality and economic burden worldwide, is not covered by the recommended initial antibiotic therapy for cancer patients with BSI. This systemic review was performed to estimate the global methicillin-r...
Topics
Open a Topic to create a Post that cites this publication.
- Antibiotic Resistance in Bacteria
- Antimicrobial Resistance in Staphylococcus
- Bacterial Identification and Susceptibility Testing
- Methicillin-Resistant Staphylococcus aureus
- Mycobacterium research and diagnosis
- Neutropenia and Cancer Infections
- Staphylococcal Infections
- Streptococcal Infections and Treatments
Identifiers and source
- Literature Corpus work
- 1ed6a487-4d64-53d3-b44f-4d45297d2da6
- DOI
- 10.21203/rs.3.rs-38902/v3
